This setting lets you change the way you view articles. You can choose to have articles open in a dialog window, a new tab, or directly in the same window.
Open in Dialog
Open in New Tab
Open in same window
Open in New Tab
Open in same window

Journal of Economic Perspectives: Vol. 27 No. 1 (Winter 2013)
JEP Volume. 27, Issue 1 |
Previous ArticleNext Article
Sign up for Email Alerts Follow us on Twitter
Full-text Article (Complimentary)
Download Data Set (21.40 MB) | Online Appendix (128.25 KB)
View Comments on This Article (0) | Login to post a comment
Previous ArticleNext Article
Expand
Quick Tools:
Print Article Summary Email Link to this Article Export CitationSign up for Email Alerts Follow us on Twitter
Explore:
The RAND Health Insurance Experiment, Three Decades Later
Article Citation
Aron-Dine, Aviva,
Liran Einav, and
Amy Finkelstein. 2013. "The RAND Health Insurance Experiment, Three Decades Later."
Journal of Economic Perspectives,
27(1): 197-222.
DOI: 10.1257/jep.27.1.197
DOI: 10.1257/jep.27.1.197
Abstract
Between 1974 and 1981, the RAND health insurance experiment provided health insurance to more than 5,800 individuals from about 2,000 households in six different locations across the
United States, a sample designed to be representative of families with adults under the age of 62. More than three decades later, the RAND results are still widely held to be the "gold standard" of
evidence for predicting the likely impact of health insurance reforms on medical spending, as well as for designing actual insurance policies. On cost grounds alone, we are unlikely to see
something like the RAND experiment again. In this essay, we reexamine the core findings of the RAND health insurance experiment in light of the subsequent three decades of work on the
analysis of randomized experiments and the economics of moral hazard. First, we re-present the main findings of the RAND experiment in a manner more similar to the way they would be
presented today. Second, we reexamine the validity of the experimental treatment effects. Finally, we reconsider the famous RAND estimate that the elasticity of medical spending with
respect to its out-of pocket price is -0.2. We draw a contrast between how this elasticity was originally estimated and how it has been subsequently applied, and more generally we caution
against trying to summarize the experimental treatment effects from nonlinear health insurance contracts using a single price elasticity.
Article Full-Text Access
Full-text Article (Complimentary)
Additional Materials
Download Data Set (21.40 MB) | Online Appendix (128.25 KB)
Authors
Aron-Dine, Aviva (MIT)
Einav, Liran (Stanford U)
Finkelstein, Amy (MIT)
Einav, Liran (Stanford U)
Finkelstein, Amy (MIT)
JEL Classifications
G22: Insurance; Insurance Companies
I13: Health Insurance, Public and Private
I18: Health: Government Policy; Regulation; Public Health
I13: Health Insurance, Public and Private
I18: Health: Government Policy; Regulation; Public Health
Comments
View Comments on This Article (0) | Login to post a comment

